Home › Markets › Health Care › DRIO

DarioHealth Corp. (DRIO)

DRIO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$5.54
+2.21% on the day
Market cap
$54.3M
Micro cap
Revenue · 2025
$22.4M
No prior year to compare
Net income · 2025
-$41.7M
-186.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1533998/000110465926031621/0001104659-26-031621-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.

Profile

FieldValue
TickerDRIO on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryIsrael
IPO yearNot reported by the screener
SEC CIK0001533998
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$22.4M
Net income-$41.7M
Operating income-$36.7M
Net margin-186.6%
Operating margin-163.9%
Revenue growthNo prior-year revenue to compare
Cash$21.8M
Total assets$110.1M
P/E (computed)Net income was not positive
P/S (computed)2.4×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-22
Latest annual report10-K2026-03-19
Latest quarterly / interim10-Q2026-08-11
Latest current report
FORM 8-K
8-K2026-09-04
Latest proxy
FORM DEF 14A
DEF 14A2025-12-22

Source: SEC EDGAR submissions feed, 903 recent filings. All filings on EDGAR.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
GUTSFractyl Health Inc.$4.03-8.73%$53.4M
MDAISpectral AI Inc.$1.56-2.50%$50.2M
DXRDaxor Corporation$10.35+0.45%$60.4M
SNWVSANUWAVE Health Inc.$5.61-3.94%$48.3M
TELATELA Bio Inc.$1.06-1.39%$48.1M
SRTSSensus Healthcare Inc.$2.89-1.36%$47.6M
XTNTXtant Medical Holdings Inc.$0.3243-1.43%$45.5M
MBOTMicrobot Medical Inc.$1.02-1.92%$68.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier